AN OPEN LABEL EXTENSION STUDY OF ETRIPAMIL NASAL SPRAY IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

Registry ID

MSP-2017-1278

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

MILESTONE PHARMACEUTICALS INC

Start date

2022-02-28

Completion date

2024-09-17

Last update

2021-01-19

Conditions

• PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT)

Related clinical trials

• MULTI-CENTER, MULTI-NATIONAL, OPEN-LABEL, EFFICACY AND SAFETY STUDY OF ETRIPAMIL NASAL SPRAY IN PEDIATRIC PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
• MULTI-CENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY, AND SAFETY STUDY OF ETRIPAMIL NASAL SPRAY FOR THE TERMINATION OF SPONTANEOUS EPISODES OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

View on source registry